In both subjects changes of cortical activity had the quality of suddenness; the cortical rhythm changing from normality to gross abnormality over a narrow range of B.P. In the normal subject the upper limit of this range was 55 mm.Hg systolic, and in the arteriosclerotic about 75 mm.Hg.
The recovery of the two cases was very different. Whereas the normal subject (Case II) recovered rapidly and completely once the blood pressure rose above 50 mm.Hg, the arteriosclerotic subject showed a delayed recovery of consciousness and cortical rhythm, long after the B.P. had been restored to levels well above the point at which cerebral functions had first become disturbed.
Herein may lie the explanation of prolonged recovery times sometimes seen in patients submitted to controlled hypotension by means of posture and vasodilator drugs. It may be that cerebral anoxia, and not the anesthetic drug, is responsible for the prolonged coma.
SUMMARY
The electroencephalogram (EEG) has been used as an index of cerebral cellular anoxia in induced vascular hypotension.
Three conscious subjects were submitted to induced vascular hypoten&ion by a combination of posture and a vasodilator drug. Continuous EEG recordings were made throughout the experiments.
In one subject the blood pressure failed to reach critical levels. In the other two subjects severe hypotension was accompanied by coma, convulsions, and profound disturbance of cortical rhythm. Recovery was prompt in a normal volunteer, but markedly delayed in an arteriosclerotic subject.
The significance of these findings is discussed in relation to ischaemic cerebral anoxia.
The Depression of Respiration by the Opiates and Its Antagonism by Nalorphine By R. I. BODMAN, M.B., D.A.
Hillingdon Hospital, Middlesex
A NEW colour film entitled "Nalorphine" was shown by courtesy of the Wellcome Research Institution. The film demonstrated the action of nalorphine as an antagonist to morphine, methadone and thiambutene. A dog was shown deeply narcotized with morphine; nalorphine was injected into a leg vein and the dog woke up with startling rapidity-in twelve seconds he was sitting up and in half a minute he was running round.
All the effects of morphine are antagonized by nalorphine. The depressant effect on the respiration of a dog was shown to disappear in less than a minute. The effects on temperature were shown in rabbits: morphine alone produces a fall in temperature, if nalorphine is given simultaneously with morphine then there is only a very slight fall, comparable with that produced by nalorphine alone. The effect on gastro-intestinal propulsion was shown in rats: morphine alone causes a marked delay in the passage of food, nalorphine alone hardly any delay; morphine and nalorphine given together cause little more delay than nalorphine alone.
Methadone and its analogues, also pethidine and thiambutene share the actions of morphine and are antagonized by nalorphine. This was demonstrated on two animals, one narcotized with methadone and the other with thiambutene.
Respiratory depression I take to be a reduction in respiratory minute volume. This may be brought about in three ways: first, by a reduction in respiratory rate, the tidal volume remaining the same; secondly by a reduction in tidal volume, the rate remaining constant; or thirdly by a combination of both.
TInder the conditions of modem anxsthetic practice the first two types of respiratory depression can be demonstrated quite distinctly. Pethidine, for instance, given intravenously in the doses usually used, causes a slowing of respiration, with little change in the tidal volume, while the barbiturates, represented by thiopentone, have little effect on the rate of respiration but reduce the tidal volume ( Fig. 1 ). It is interesting to observe in Fig. 1 that although thiopentone produced a more profound depression, as apnoea persisted for two minutes, the minute volume was restored within five minutes; whereas the respiratory rate of the patient who received pethidine did not return to its previous figure for forty minutes. These two types of respiratory depression may be tabulated thus: They are so distinct that one can hardly avoid concluding that they originate at different sites in the central nervous system, and consequently may be expected to be affected by different circumstances and drugs. For the purposes of this paper I am calling pethidine an opiate. In fact my experience with making respiratory tracings of the effects of pethidine, morphine and papaveretum over the last three years has revealed no essential difference between them, except that for a corresponding deptb of depression, pethidine has a shorter duration of action than the naturally occurring drugs.
The depressing effect of the opiates on the respiration may be demonstrated in three ways:
(1) By counting the respiration rate.
(2) By measuring the minute volume, e.g. with Gaddum's spirometer.
(3) By stimulating the respiratory centre with carbon dioxide. (1) Counting the respiration rate demonstrates that the depressing effect of pethidine given intravenously during anesthesia is influenced by the dose of papaveretum given for premedication.
Each patient's respiration was recorded and the rate plotted as in Fig. 2 927 minutes BEFORE injection was then plotted against the rate for the slowest five minutes AFTER. Fig. 3 shows the results obtained in this way for two groups, the patients in the first group were premedicated with -1 grain omnopon and in the second group with I grain omnopon. Each patient was given 0*5 gramme thiopentone, 75 % nitrous oxide and 50 mg. of pethidine. The depression of respiration after I grain of omnopon is greater than that followinggrain. It is my impression that patients breathing at less than six per minute cannot maintain full oxygenation with 25% oxygen: if a line is drawn across at this rate it will be seen that only 2 patients of the 19 receiving W grain omnopon come into this category, while10 of the 23 receiving I grain breathe at less than 6 per minute.
(2) Fig. 4 shows the effect of 50 mg. pethidine on the minute volume of a patient, using Gaddum's spirometer (1941) .
(3) The effect of pethidine on the response to carbon dioxide is shown in Fig. 5 . These tracings were made with a cuff round the chest and a Marey's tambour; they start with the patients awake. Each patient was given 0 5 gramme thiopentone, nitrous oxide, oxygen and CO? as indicated. The second patient was also given 50 mg. pethidine beforehand, this resulted in a much diminished respon3e to CO2.
Having defined respiratory depression and shown in various ways how it is brought about by the opiates, and, in particular, by pethidine, we can proceed to consider the new drugAr-allylnormorphine. N-allylnormorphine is now officially called nalorphine, it is available under the trade name "Lethidrone". Fig. 6 shows how similar is its structure to the morphine molecule. is removed from the nitrogen, hence the term NOR from the German "Nitrogen ohne radicale".
An allyl group is substituted (which really renders the NOR a misnomer). As might be expected from their similar structure the mode of action of nalorphine is believed to be a substrate competition for the same receptors that are affected by morphine.
In 1915 Pohl described AN-allylnorcodeine as being able to antagonize the respiratory depression of morphine. AN-allylnormorphine was synthesized by McCawley, Hart and Marsh in 1941. IJnna carried out a number of experiments on dogs in 1943 and showed that nalorphine could rouse dogs anesthetized with morphine.
Nalorphine seems to have been first tried in man for the treatment of morphine addiction: Wikler (1951) reported giving it to 12 post-addicts in whom it produced lethargy, mild drowsiness, vivid daydreams and dysphoria. In another paper, Wikler et al. (1952) reported that nalorphine produced the most intense abstinence syndrome ever observed in an institution for treating morphine addicts.
Eckenhoff, Elder and King (1951) showed that nalorphine was effective in relieving respiratory depression due to morphine and pethidine during anaesthesia, but was ineffective against depression due to cyclopropane, ether and thiopentone: this is not surprising, as I have shown that the respiratory depression due to thiopentone at any rate, is of quite a different type. During anesthesia, nalorphine injected intravenously into a patient whose respiration has been depressed by an opiate restores the normal rate within half a minute. Fig. 7 shows the dramatic effect; the time marker indicates minutes and the numerals the respiration rate. The tracing reads from left to right: inspiration is downwards: the lower line follows after a delay of six minutes. There is no initial stimulation of respiration, but an abrupt return to normal rate, which is maintained. This contrasts with the effect of an analeptic, an example of which is Fig. 8 , which shows the NIK .  FIG. 8. -Effect of nikethamide (NIK) on respiration depressed by pethidine. typical effect of nikethamide. Two ml. of this were injected into a patient anesthetized with thiopentone, gas, oxygen and pethidine: the patient practically woke up, coughed,then settled down and carried on breathing at a rate of 9-10 per minute.
The effect of nalorphine on the minute volume can be seen in Fig. 9 , using Gaddum's spirometer; this is the same case as Fig. 4 , the minute volume is abruptly returned to normal. Having confirmed the remarkable antagonism of nalorphine for pethidine I attempted to determine the minimum dose necessary to restore the respiratory rate after a dose of 50 mg. of pethidine given intravenously. This was done by giving the pethidine and following it after five minutes with nalorphine given 1 mg. at a time at two-minute intervals, until no further increase in rate occurred. shows a typical result. Another point also emerges; a second dose of pethidine repeated after the nalorphine does not produce the characteristic slowing effect. It appears that nalorphine once established is not easily dislodged from the receptors for which it and pethidine compete. 3 mg. of nalorphine also restored the normal respiratory rate following the slowing caused by J grain omnopon intravenously. Nalorphine is also reported to be effective against the other synthetic opiates-physeptone and methorphinan (Chase et al., 1952) as well as against the side-effects of morphine, e.g. hyperglycaemic effect and the increased activity in the bowel (Beal and Schapiro, 1953) . Up to the present,-what may be called the morphine syndrome-pain-relief, respiratory depression, pin-point pupils and addiction-has remained indissoluble. But the appearance of nalorphine, a drug which completely antagonizes the respiratory depression, must lead one to consider whether a combination of drugs may not produce some pain-relief with a minimum of respiratory depression. Fig. 11 shows the analgesic effect of pethidine as reflected in the respiratory pattern. A man was intubated for radical mastoidectomy with F gramme of thiopentone and 50 mg. of succinyl choline. Respiration returned and showed the irregular and hesitant form characteristic of a patient who does not tolerate an endotracheal tube. A dose of pethidine was given and the respiration changed to a regular form. An injection of nalorphine restored the rate to normal with no alteration in the rhythm at first, but after four minutes this suddently reverted to the irregular character seen at the beginning.
Finally, a second dose of pethidine was given, the respiration again became regular, but on this occasion no slowing took place. The surgical stimulus while this tracing was being made remained, to all intents and purposes, the same and consisted in the surgeon hitting the patient's head with a mallet and chisel: an exercise designed to try anyone's tolerance of an endotracheal tube.
There are three points to notice here. First, after the original dose of pethidine the respiration became regular before it slowed. Secondly, after the dose of nalorphine the respiration rate reverted to normal some four minutes before the surgical stimulus eventually broke through and set up the irregular rhythm again.
If we take the regularity of the respiration to indicate a measure of analgesia, we can infer that the analgesic effect of pethidine precedes the respiratory depression, as shown by the slowing of the rate. Thirdly, this is borne out by the effect of the second dose of pethidine which produced a regular rhythm at a normal rate.
Here, then, seems to be a possibility that the analgesic and respiratory depressing effects of the opiates may be separated. It may be that a carefully determined dose of nalorphine will antagonize the respiratory depression leaving a measure of analgesia. In order to test this, I have in a number of cases given 50 mg. of pethidine together with 3 mg. of nalorphine and obtained, I believe, some analgesic effect. This seems to me to be a line worth pursuing. Now that there is an effective antagonist to the opiates the possibility of using sensory depression in place of muscular par'alysis comes nearer achievement. The production of apnoea with very large doses of pethidine combined with hyperventilation may be used to replace muscle-relaxants. This would appear to be most likely in chest surgery, where relaxants are at present used not to gain access, as in abdominal surgery, but to keep the diaphragm still and to control the patient's tidal exchange.
The question of the use of nalorphine in midwifery is too large to embark on now; but there seem to me three ways in which its use might be explored. First, to give it some time before the opiates or pethidine so that it saturates the infant, before the mother receives her analgesia. Secondly, large doses of opiates may be given to the mother and their effect reversed just before delivery; or thirdly, the drug may be given to the infant after delivery as described by Eckenhoff, Hoffman and Dripps (1952) . I have given doses of f mg. to two infants delivered unexpectedly quickly after omnopon, with good results.
It occurred to me that we might be able to use larger doses of pethidine or morphine as a supplement to nitrous oxide in the casualty theatre, following them with a dose of nalorphine, before sending the patient home. Before doing this we decided to try the drug on ourselves; three of us each had 3 mg.
intravenously. My two colleagues thought the word "dysphoria" did less than justice to their feelings. They sweated, shivered and felt sick and giddy for an hour after the injection and did not return to normal for nearly three hours. I had a feeling of heaviness in the head and felt slightly unsteady but this was relieved by undoing my tie. A sensation of unreality supervened for some time but did not prevent my eating a good tea half an hour after the injection. In view of the unpleasant symptoms experienced by my colleagues, I thought it hardly fair to give nalorphine to out-patients.
To summarize the uses to which nalorphine might be put I suggest:
(1) In the treatment of opium poisoning; including inadvertent overdoses to infants, the cachectic and shocked, and chronic bronchitic or emphysematous patients, who are particularly sensitive to the opiates.
(2) In the treatment of addiction.
(3) As an aid in the diagnosis of a patient with an acute abdomen who has ill-advisedly been given morphine.
(4) Combined with the opiates in midwifery-to the mother before delivery or to the infant after.
(5) As an aid to anesthesia, allowing us to use the opiates more freely.
SUMMARY
Respiratory depression is defined and the difference between that produced by the opiates and the barbiturates is illustrated by tracings from anaesthetized patients. The antagonism of a -new drug, N-allylnormorphine, for the opiates is demonstrated. The possibility of producing analgesia without respiratory depression by a combination of drugs is discussed.
